HOME >> BIOLOGY >> NEWS
Jefferson researchers' discovery may change thinking on how viruses invade the brain

(PHILADELPHIA) -- A molecule thought crucial to ferrying the deadly rabies virus into the brain, where it eventually kills, apparently isnt. The surprising finding, say researchers at Jefferson Medical College in Philadelphia, may change the way scientists think about how central nervous system-attacking viruses such as herpes viruses invade the brain and cause disease.

According to Matthias Schnell, Ph.D., professor of microbiology and immunology at Jefferson Medical College of Thomas Jefferson University, viruses such as rabies must be actively transported to the brain and central nervous system. The LC8 protein was thought to tether viruses to the cellular transport machinery in order to get there.

But Dr. Schnell and his co-workers found that this protein complex is instead a "transcription factor" that plays a role in virus reproduction. "We think that this finding has implications not only for rabies but many viruses that previously were thought to use this complex for transport, such as herpes viruses," he says. They report their results online this week in the journal Proceedings of the National Academy of Sciences.

To understand the role of LC8 in rabies disease in the brain, the team compared a rabies virus strain with the LC8 "binding domain" (where the rabies virus and LC8 protein interact) to a virus lacking it. They showed that in mice that were infected with rabies without the LC8 binding domain, the virus was still able to infect the brain, but did not cause disease. The virus ability to reproduce was greatly diminished.

"What we found has nothing to do with transport," Dr. Schnell says. "We saw that the virus was weakened if we removed the LC8 binding site and viral replication and transcription were affected. But we didnt find a difference in the initial viral entry in the central nervous system. We actually saw that the virus replicated better with the binding site than without it. LC8 is a transcripti
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
19-Apr-2007


Page: 1 2

Related biology news :

1. Jefferson scientists patent dramatically improves
2. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
3. Tiny genes may increase cancer susceptibility, Jefferson scientists find
4. Jefferson scientists use gene therapy to reverse heart failure in animals
5. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
6. Jefferson scientists find rabies-based vaccine could be effective against HIV
7. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer
8. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
9. Jefferson scientists find guardian genes choices crucial to stopping cancer process
10. Jefferson researchers uncover new way nature turns genes on and off
11. Jefferson researchers develop combined procedure for uterine preservation in treating fibroids

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 16, 2019 , ... uBiome, the leader ... platform that uses artificial intelligence (AI) and a data-centric approach to decentralize medicine ... ulcerative colitis. , People will Crohn’s or other chronic medical conditions join a ...
(Date:1/20/2019)... , ... January 18, 2019 , ... Boston-based Laboratory as ... in an effort to better express its continued expansion and service offerings for ... for a new kind of lab: one that is more agile and adaptable than ...
(Date:1/10/2019)... ... ... Dr. Beanlands is the Vered Chair and Division Head of Cardiology at ... Director of its National Cardiac PET Centre, and Professor in the University's Division of ... Department of Cellular and Molecular medicine. , He is a founding member of ASNC, ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... ... ... Dr. Douglas Stramel of Advanced Care Veterinary Services in Carrollton, ... for nearly three years. A proponent of Regenerative Medicine, Dr. Stramel has been ... V-PET™ 2016. V-PET™ is a gravity filtration-based platelet therapy kit that produces a ...
(Date:1/20/2019)... ... 16, 2019 , ... On January 15 of this year, the Parents’ Guide ... director James L. Sherley, M.D., Ph.D. The PGCB was founded by former ... CellTrials.org. Now in its 21st year of operation, the PGCB continues its mission ...
(Date:1/20/2019)... ... January 17, 2019 , ... TrakCel, ... developer, and The Quick Life Science Group (Quick Healthcare and QuickSTAT) today announce ... enables the global cell and gene therapy industry to track products and manage ...
(Date:1/11/2019)... , ... January 11, 2019 , ... Drawing on over ... Tuesday, January 22, 2019 at 2:30pm EST will explore some of the key lessons ... of using one vendor vs. using multiple vendors, and find out how to ensure ...
Breaking Biology Technology:
Cached News: